These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8187322)

  • 21. Common fibroid-associated genes are differentially expressed in phenotypically dissimilar cell populations isolated from within human fibroids and myometrium.
    Holdsworth-Carson SJ; Zaitseva M; Girling JE; Vollenhoven BJ; Rogers PA
    Reproduction; 2014 May; 147(5):683-92. PubMed ID: 24713395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
    Luo X; Ding L; Xu J; Williams RS; Chegini N
    Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
    Vollenhoven BJ; Herington AC; Healy DL
    J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
    Mozzachio K; Moore AB; Kissling GE; Dixon D
    Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
    Chegini N; Verala J; Luo X; Xu J; Williams RS
    J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
    Uemura T; Mori J; Yoshimura Y; Minaguchi H
    Asia Oceania J Obstet Gynaecol; 1991 Dec; 17(4):315-20. PubMed ID: 1724899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological differences between focal and diffuse adenomyosis and response to hormonal treatment.
    Khan KN; Fujishita A; Koshiba A; Mori T; Kuroboshi H; Ogi H; Itoh K; Nakashima M; Kitawaki J
    Reprod Biomed Online; 2019 Apr; 38(4):634-646. PubMed ID: 30850322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
    Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
    Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.
    Feng Q; Crochet JR; Dai Q; Leppert PC; Price TM
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E390-9. PubMed ID: 24423317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E; Luo X; Ding L; Williams RS; Chegini N
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin expression in human myometrium and fibroids.
    Sahlin L; Wang H; Lindblom B; Eriksson H; Holmgren A; Blanck A
    Mol Hum Reprod; 2000 Jan; 6(1):60-7. PubMed ID: 10611262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
    Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
    Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium.
    Lessl M; Klotzbuecher M; Schoen S; Reles A; Stöckemann K; Fuhrmann U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2596-600. PubMed ID: 9253340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
    Rein MS; Friedman AJ; Heffner LJ
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
    Al-Hendy A; Diamond MP; El-Sohemy A; Halder SK
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E572-82. PubMed ID: 25625804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
    Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
    Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
    Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
    Lumsden MA; West CP; Bramley T; Rumgay L; Baird DT
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1299-304. PubMed ID: 2975953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.